Meeting
2017 ASCO-SITC Clinical Immuno-Oncology Symposium
Diagnostic accuracy of molecular tumor profiling in determining the tissue of origin in adult patients with cancer of unknown primary: A meta-analysis.
Authors
Rowena Torres Inocencio
McLaren Flint Internal Medicine Department, Flint, MI
Rowena Torres Inocencio, Kavitha Kesari, Susan Smith
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Biomarkers and Inflammatory Signatures,Humoral Immunity for Diagnosis and Therapy,Immune Checkpoints and Stimulatory Receptors,Modulating Innate Immunity,Therapies Targeting T cells
Sub Track
Novel Biomarker Approaches
Citation
J Clin Oncol 35, 2017 (suppl 7S; abstract 20)
DOI
10.1200/JCO.2017.35.7_suppl.20
Abstract #
20
Poster Bd #
C3
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Molecular tumor profiling (MTP) of poorly differentiated neoplasms (PDN) of unknown primary site.
First Author: F Anthony Greco
Poster
2011 ASCO Annual Meeting
Molecular tumor profiling (MTP) in cancer of unknown primary site (CUP): A complement to standard pathologic diagnosis.
First Author: D. S. Thompson
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Utility of gene expression–based cancer classification in diagnosis of malignant peritoneal mesothelioma (MPeM): Filling in the gaps in standard pathologic work-up for a rare cancer.
First Author: Joelle Allam
Poster
2020 ASCO Virtual Scientific Program
PD-1 protein and gene expression in early breast cancer: Prognostic implications.
First Author: Ioannis Zerdes